Navigation Links
Patients report high satisfaction with pain treatment
Date:4/27/2014

lationship (e.g. provision of adequate information on pain treatment options). "We were the first research group that was able to study this topic at such a large scale, a unique opportunity. It was striking to us how consistent our results were across healthcare centers and countries", states Schwenkglenks.

Expanding patient involvement

Overall, the findings indicate that satisfaction with postoperative pain treatment is less associated with the patients' actual pain experience but rather with impressions of improvement and appropriateness of care. Specifically, the area of patient involvement in the decision making process seems to be of high importance. The study thus suggests that in the effort to manage pain effectively, it would be inappropriate to focus on low pain intensity as the only goal of postoperative pain treatment. Patients should, to the degree they desire, be provided with information and involved in pain treatment decisions.


'/>"/>

Contact: Olivia Poisson
olivia.poisson@unibas.ch
University of Basel
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Higher-spending hospitals have fewer deaths for emergency patients
2. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
3. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
4. Study finds doctors have exaggerated fears when starting patients on insulin
5. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
6. Predictors identified for rehospitalization among post-acute stroke patients
7. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Heart failure patients with diabetes may benefit from higher glucose levels
10. Gastro Woes Often Strike Rheumatoid Arthritis Patients
11. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 31, 2015 , ... “Engage: Don’t Just Age” will be ... leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino ... “C”-level executives, administrators, directors of nursing, rehabilitation managers and other management and corporate ...
(Date:7/31/2015)... ... 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based ... BioViva announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use ... cure. MaxLife will grant 100% of the money raised to BioViva to help bring ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor ... out of the window, he recalled that his equipment was set up to depict the ... he jumped out of bed. , The photo speaks for itself. Chatfield is also a ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Awarded to only ... is proud to announce that they are the latest recipients of the Center ... status as one of the worldwide leaders in the science of hair transplant. , ...
(Date:7/31/2015)... ... 2015 , ... Eldermark Software, the innovative leader of senior ... Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper is a compilation of three ... of using medication management technologies . , Eldermark’s case study ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... CEO: "This Deal Places IDE in a Key Position for ... Presence on the Australian ... TEL AVIV, Israel, August 12 IDE Technologies, jointly,owned ... Delek Group, signed a contract to supply a desalination plant ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA) ("Duska") announced today ... Drug Administration,s (the "FDA"),Division of Cardiovascular and Renal Products ... with its lead drug, ATPace(TM), for the acute,treatment of ... On April 16, 2008, Duska met with the FDA ...
... distress to improve quality of life , , TUESDAY, ... increased risk for suicide, according to three new studies. ... of Washington analyzed U.S. data from 1973 to 2002 ... was 31.4 per 100,000 person-years, compared to 16.7 per ...
... MOUNTAIN VIEW, Calif., Aug. 12 MAP,Pharmaceuticals, Inc. (Nasdaq: ... June 30, 2008., The net loss for the second ... million during the same period in 2007. The net,loss for ... to $15.3,million for the first six months of 2007. As ...
... Texas, Aug. 12 American,HealthChoice, Inc. (Pink Sheets: ... clinics in Texas and Tennessee, is pleased to ... Scan, an infrared thermal imaging camera,that will be ... human body.,In conjunction with existing technologies, the OmniBody ...
... is celebrating the opening their latest location in Anderson ... services in the senior home care area. Preferred Care ... Alabama, Missouri and Minnesota. Of interest too, is that ... Anyone who has a desire to make a difference ...
Cached Medicine News:Health News:IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 4Health News:Older Patients With Cancer at Heightened Suicide Risk 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 5Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 6Health News:American HealthChoice Announces Launch of OmniBody Scan 2Health News:American HealthChoice Announces Launch of OmniBody Scan 3Health News:Senior Home care Providers keep Expanding Throughout the US 2Health News:Senior Home care Providers keep Expanding Throughout the US 3
(Date:7/31/2015)... Ill. , July 31, 2015 ... ® (NABP ® ) issued a report ... ensuring that action is taken against websites illegally ... Internet Drug Outlet Identification Program Progress Report ... , thousands of websites illegally distribute ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, today ... to its board of directors. "Yujiro,s ... a tremendous asset to our board," said Bassil ... Xencor. "Xencor faces a range of opportunities for our ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Conn., Oct. 6 The Hedgeye Risk Management Healthcare team, led ... Conference Call, "Aging of America: Demographics of Demand and Profits in ... long tail of demographics, why 1994-2002 was so good, and why ... device demand, and the outlook for hip, knee, and spine device ...
... Oct. 6 Roxane Laboratories, Inc. announced today ... (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg ... Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. ... for immediate shipment to wholesalers and pharmacies nationwide. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
Medicine Products: